NewEdge Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-56
| Closed | -$1.36K | – | 4018 |
|
|
2025
Q1 | $1.36K | Buy |
56
+1
| +2% | +$24 | ﹤0.01% | 3582 |
|
|
2024
Q4 | $1.15K | Buy |
+55
| New | +$1.15K | ﹤0.01% | 3543 |
|
|
2024
Q3 | – | Sell |
-70
| Closed | -$1.08K | – | 3841 |
|
|
2024
Q2 | $1.08K | Hold |
70
| – | – | ﹤0.01% | 3455 |
|
|
2024
Q1 | $1.12K | Hold |
70
| – | – | ﹤0.01% | 3477 |
|
|
2023
Q4 | $1.18K | Sell |
70
-3,196
| -98% | -$53.7K | ﹤0.01% | 3438 |
|
|
2023
Q3 | $38.2K | Buy |
3,266
+226
| +7% | +$2.64K | ﹤0.01% | 2177 |
|
|
2023
Q2 | $40.9K | Sell |
3,040
-18,626
| -86% | -$250K | ﹤0.01% | 2153 |
|
|
2023
Q1 | $359K | Sell |
21,666
-8,392
| -28% | -$139K | ﹤0.01% | 1283 |
|
|
2022
Q4 | $331K | Buy |
30,058
+1,223
| +4% | +$13.5K | 0.01% | 955 |
|
|
2022
Q3 | $370K | Buy |
+28,835
| New | +$370K | 0.01% | 1095 |
|
|
2022
Q2 | – | Sell |
-19,189
| Closed | -$159K | – | 1571 |
|
|
2022
Q1 | $159K | Buy |
+19,189
| New | +$159K | ﹤0.01% | 1036 |
|